Gara Jalqabaatti › Leukemia Myeloidii Hamaa › Iowa › Cedar Rapids
Qorannoo klinikaalii Leukemia Myeloidii Hamaa Cedar Rapids, IA keessatti
Qorannoo 16 Leukemia Myeloidii Hamaa f Cedar Rapids fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Mercy Hospital, Cedar Rapids
- Oncology Associates at Mercy Medical Center, Cedar Rapids
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Miili 25 fagaatti
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Miili 25 fagaatti
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Miili 25 fagaatti
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
Namoota walitti qabaa jiraSadarkaa 2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Miili 25 fagaatti
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Namoota walitti qabaa jiraSadarkaa 3
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Miili 25 fagaatti
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Iowa Hospital, Iowa City · Miili 25 fagaatti
A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Iowa Hospital and Clinics, Iowa City · Miili 25 fagaatti
High-dose Ascorbate (HDA) in Combination With Standard of Care Azacitidine and Venetoclax in Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 1
- University of Iowa Health Care, Iowa City · Miili 25 fagaatti
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Iowa/Holden Comprehensive Cancer Center, Iowa City · Miili 25 fagaatti
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Namoota walitti qabaa jiraSadarkaa 3
- University of Iowa Stead Family Children's Hospital, Iowa City · Miili 25 fagaatti
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Namoota walitti qabaa jiraSadarkaa 3
- University of Iowa, Iowa City · Miili 25 fagaatti
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Namoota walitti qabaa jiraSadarkaa 1
- University of Iowa Hospitals & Clinics, Iowa City · Miili 25 fagaatti
Mocravimod as Adjunctive and Maintenance Treatment in AML Patients Undergoing Allo-HCT
Namoota walitti qabaa jiraSadarkaa 3
- University of Iowa Hospitals and Clinics, Iowa City · Miili 25 fagaatti
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Namoota walitti qabaa jiraQorannoo ilaalaa
- University of Iowa, Iowa City · Miili 25 fagaatti
A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Namoota walitti qabaa jiraSadarkaa 1
- University of Iowa Hospitals & Clinics, Iowa City · Miili 25 fagaatti
Qorannoo Leukemia Myeloidii Hamaa magaalota biroo keessatti
- Houston, TXQorannoo 85
- New York City, NYQorannoo 51
- Boston, MAQorannoo 44
- Baldwin Park, CAQorannoo 40
- Seattle, WAQorannoo 40
- Columbus, OHQorannoo 35
- Philadelphia, PAQorannoo 34
- Durham, NCQorannoo 33
- Atlanta, GAQorannoo 30
- Tampa, FLQorannoo 29
- Chicago, ILQorannoo 26
- Portland, ORQorannoo 25
Qorannoo biroo Cedar Rapids keessatti
- Kansara Qara'a Non-Small CellQorannoo 20
- Saree OljooQorannoo 17
- Saree (Gosoota Hunda)Qorannoo 15
- Myeloma Baay’eeQorannoo 15
- Dhibee QaraQorannoo 14
- Kansarii ColorectalQorannoo 13
- Kansarii ProstateQorannoo 12
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 12
- MelanomaQorannoo 10
- StrokeQorannoo 10
- Kansara MetastatikiiQorannoo 9
- Kansa EndometiriyaaliiQorannoo 9
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.